Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-03-27 @ 1:30 PM
Study NCT ID:
NCT02657434
Status:
COMPLETED
Last Update Posted:
2023-11-21
First Post:
2016-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-14
First Submit QC Date:
None
Study First Post Date:
2016-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-07
Results First Submit QC Date:
None
Results First Post Date:
2020-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2023-11-21
Last Update Post Date Type:
ACTUAL